Gilead Sciences, Inc.’s Stock Price Drops to $118.84, Marking a 3.70% Decrease

Gilead Sciences, Inc. (GILD)

118.84 USD -4.56 (-3.70%) Volume: 9.02M

Gilead Sciences, Inc.’s stock price is currently at 118.84 USD, experiencing a decrease of -3.70% this trading session with a trading volume of 9.02M. Despite the recent drop, GILD’s stock has shown a strong performance YTD, recording a positive change of +28.89%, showcasing the company’s resilience and potential for growth.

Latest developments on Gilead Sciences, Inc.

Gilead Sciences, Inc. (GILD) has been making headlines recently with the Phase 3 trial for Trodelvy falling short, causing some investors to question if now is a good time to buy. Despite this setback, the company provided an update on the ASCENT-07 study and saw a boost in stock position from Sienna Gestion. While some institutions like Achmea Investment Management B.V. and Andra AP fonden increased their stake in Gilead, others like Sprucegrove Investment Management Ltd. and Commonwealth Retirement Investments LLC sold shares. With mixed analyst ratings and price target adjustments, the future of Gilead Sciences, Inc. stock remains uncertain, but the sustained efficacy of Livdelzi® in treating primary biliary cholangitis offers hope for potential growth.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma